Several reports have shown that AT1aR and AT1bR subtypes each exhibit unique regulatory functions (3,21,32). pharmacological antagonists, icv injections of either recombinant adeno-associated computer virus transporting siRNA silencers of AT1aR (AT1aR-siRNA) or MR (MR-siRNA) significantly attenuated the development of Aldo-induced hypertension. The immunohistochemical and Western blot analyses of AT1aR-siRNA- or MR-siRNA-injected rats showed a marked reduction in the expression of AT1R or MR in the paraventricular nucleus compared with scrambled siRNA rats. When animals from all studies underwent ganglionic blockade with hexamethonium, there was a smaller reduction in the fall of BP in animals receiving icv AT1R or MR antagonists. These results suggest that ANG II and Aldo interact in the brain in a mutually cooperative manner such that the functional integrity of both brain AT1R and MR are necessary for hypertension to be induced by either systemic ANG II or Aldo. The pressor effects produced by systemic ANG II or Aldo involve increased central ROS and sympathetic outflow. Keywords:blood pressure, reactive oxygen species, Tgfb3 sympathetic nervous system it is well establishedthat the renin-angiotensin-aldosterone (Aldo) system (RAAS) is a major regulator of sodium and potassium balance, blood volume, and blood pressure (BP) (38). Angiotensin II (ANG II) has been considered to be the principal effector of the RAAS. The major cardiovascular actions GPDA of ANG II are mediated via the angiotensin type 1 receptor (AT1R), and AT1R blockers have been shown GPDA to have therapeutic benefits in the treatment of hypertension and heart failure (6,55). In recent years, Aldo has also become recognized as an important component and mediator of the effects of the RAAS, and this steroid plays an important role in the pathophysiology of cardiovascular disease. The additional benefit of the use of mineralocorticoid receptor (MR) antagonists in conjunction with ANG II therapies highlights the clinical relevance of an ANG II/Aldo-interdependent humoral network (47). Therefore, a better understanding of the variety and sites of such interactions will lead to insights providing improved treatment of patients. Besides the well-known effect of ANG II in stimulating Aldo production from your adrenal cortex, a reciprocal conversation has been reported between hormones in extra-adrenal tissues (46,52,61). Aldo increases ANG II GPDA binding, upregulates the expression of AT1R and angiotensin-converting enzyme (ACE), and potentiates ANG II-stimulated intracellular signaling and proliferation in peripheral cardiovascular tissues (7,1517,34,35,46,53,57). In cultured rat neonatal cardiomyocytes, an ANG II receptor antagonist has been shown to inhibit Aldo-induced IL-18 expression (7). Moreover, Lemari et al. (30) exhibited that vascular easy muscle mass cell (VSMC) activation of signaling pathways such as ERK1/2, JNK, and NF-B in response to Aldo requires a functional AT1aR. These results suggest GPDA that Aldo induces vascular damage, endothelial dysfunction, and myocardial fibrosis, which depends in part on activation of an ANG II/AT1R-mediated pathway. Conversely, ANG II directly stimulates nuclear localization of MR, and MR antagonism inhibits ANG II-mediated, MR-dependent gene expression in human coronary artery easy muscle cells. GPDA ANG II-mediated MR activation is also inhibited by an AT1R antagonist, demonstrating a link between AT1R activation and MR transcriptional activation (24). Accordingly, a study by Min et al. (35) exhibited that Aldo and ANG II can synergistically promote rat VSMC mitogenesis via the conversation of the AT1R with MR. Taken together, these studies from peripheral cardiovascular tissues strongly suggest that ANG II and Aldo may modulate signaling pathways and cardiovascular function either synergistically or via a cross-talk of their receptors or their respective messenger systems. Recently, it has been shown that Aldo significantly increased the number and expression of AT1Rs and ACEs in the brain (63,64). Mineralocorticoid pretreatment can enhance ANG II-induced neuronal excitation in the preoptic/medial septum region (36). However, there have been few studies investigating the central interactions between ANG II and Aldo. Numerous in vitro and in vivo studies have demonstrated a direct role of Aldo in the development of cardiovascular disease via oxidative stress (11,36,43,48). Long-term administration of an NADPH oxidase inhibitor, apocynin, in the drinking water to deoxycorticosterone acetate (DOCA)-salt rats significantly decreased systolic BP and superoxide production in aortic rings compared with.